Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Ann Thorac Surg. 2020 Mar;109(3):678-685. doi: 10.1016/j.athoracsur.2019.07.015. Epub 2019 Aug 28.
Up to 30% of patients presenting with ascending aortic disease are deemed inoperable. Ascending aortic endovascular repair provides an alternative option for these patients.
From 2018 to 2019, 13 patients who were considered to have prohibitive risk for open ascending aortic repair underwent endovascular repair. Aortic disease included type A dissection (n = 8), pseudoaneurysm (n = 3), penetrating ulcer (n = 3), and chronic aortic aneurysm (n = 1). Ascending aortic stent placement with thoracic endovascular aortic repair was performed in 9 patients, endovascular cuff extension was inserted in 3, and in 1 patient endovascular coil embolization was undertaken. Preoperative and follow-up electrocardiogram-gated computed tomographic analysis was performed to compare the remodeling effect of the stent on the aorta. The median follow-up time was 13 months.
The stent graft was successfully implanted in all patients (100%). Operative mortality and stroke rate were 15% (2 of 13) and 8% (1 of 13), respectively. One patient required transcatheter aortic valve replacement for severe aortic insufficiency 5 months after ascending thoracic endovascular aortic repair. The location of the aortic pathologic process was in zone 0A in 2 patients, zone 0B in 7 patients, and zone 0C in 3 patients. No endoleak was observed after the ascending endovascular repair in 9 patients (70%). Follow-up computed tomographic scan analysis revealed a tendency of favorable aortic remodeling in the mid-ascending and descending aorta.
Ascending aortic stent placement for ascending aortic disease is feasible and is associated with favorable aortic remodeling. Despite persistent perfusion to the false lumen in a subset of patients, there is minimal aortic dilation at short-term follow-up with excellent survival.
多达 30%的升主动脉疾病患者被认为不适合手术。升主动脉血管内修复为这些患者提供了另一种选择。
2018 年至 2019 年,对 13 名被认为行升主动脉开放修复手术风险过高的患者进行了血管内修复。主动脉疾病包括 A 型夹层(n=8)、假性动脉瘤(n=3)、穿透性溃疡(n=3)和慢性主动脉瘤(n=1)。9 例患者行升主动脉支架置入+胸主动脉腔内修复术,3 例患者行血管内套袖延长术,1 例患者行血管内线圈栓塞术。对术前和随访的心电图门控计算机断层分析以比较支架对主动脉的重塑效果。中位随访时间为 13 个月。
所有患者(100%)均成功植入支架移植物。手术死亡率和卒中率分别为 15%(2/13)和 8%(1/13)。1 例患者在升主动脉血管内修复后 5 个月因严重主动脉瓣关闭不全需要经导管主动脉瓣置换术。2 例患者的主动脉病变部位位于 0A 区,7 例患者位于 0B 区,3 例患者位于 0C 区。9 例(70%)患者升主动脉血管内修复后无内漏。随访 CT 扫描分析显示升主动脉和降主动脉中段有良好的主动脉重塑趋势。
升主动脉疾病行升主动脉支架置入是可行的,与良好的主动脉重塑相关。尽管部分患者的假腔仍持续灌注,但在短期随访中主动脉扩张极小,生存率高。